UNITY Biotechnology Files for Voluntary Dissolution, Begins Liquidation Process After Shareholder Approval
I'm PortAI, I can summarize articles.
UNITY Biotechnology Inc. has initiated its voluntary dissolution process following shareholder approval. The company has entered a Lease Termination Agreement for its South San Francisco office, terminating the lease early on March 31, 2026. A certificate of dissolution was filed with the Delaware Secretary of State on September 26, 2025, effective the same day. As part of this process, UNITY has closed its transfer books, restricting the transfer of its common stock except in limited circumstances.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments